Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-CoV2 Infection

NCT04367883 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.

NCT NCT04367883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-CoV2 Infection
Lead sponsor
Consorci Sanitari de Terrassa
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2020
Completion date
February 24, 2028
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ace inhibitors, amantadine, antihistamine allergy, arb, covid19, influenza vaccination